Boston Scientific to buy Axonics, LivaNova winds down one of its business units

Fast Five Medtech News Podcast

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, January 8, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. The FDA cleared Butterfly Network's next-generation handheld ultrasound technology. Fast Five hosts Sean Whooley and Danielle Kirsh take a look at the technology and the recent steps taken by Butterfly Network to continue growing its business. Medtronic won CE mark approval for the MiniMed 780G automated insulin pump with the Simplera Sync disposable, all-in-one CGM. Find out more details on the company's newest CGM technology and how it can benefit people with diabetes in Europe with this approval. Abbott has integrated its FreeStyle Libre 2 Plus into Tandem Diabetes Care's automated insulin pump technology. The hosts break down the latest CGM-insulin pump integration news and look at how this can benefit people with diabetes. LivaNova plans to wind down its advanced circulatory support business unit. The company is the latest to take action to narrow its focus by shifting its organizational structure. Learn more about what this decision entails. Boston Scientific plans to acquire Axonics for $3.7B. One of the busiest companies on the M&A front in medtech has made yet another move, with this one providing a major boost to its Urology portfolio. The Fast Five hosts explain the details of the acquisition and how it folds into Boston Scientific's broader strategy.